| 摘要 |
Disclosed is a vaccine comprising at least two fragments of Proprotein convertase subtilisin/kexin type 9 (PCSK9), wherein at least one fragment of said at least two fragments comprises at least 8 consecutive amino acid residues of amino acid residues 150 to 170 of PCSK9 according to SEQ ID No. 9 and wherein at least one fragment of said at least two fragments comprises at least 8 consecutive amino acid residues 205 to 225 of PCSK9 according to SEQ ID No. 9, wherein SEQ ID NOs: 8 and 9 are disclosed within the specification. |
